Internal Medicine · Wildomar, CA
NPI
1750486015
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
4
Medicare group memberships
Hospitals
2
Hospital affiliations
36485 Inland Valley Dr
Wildomar, CA, 92595
Phone (570) 971-8731
Groups this clinician bills Medicare through
Medicare paid, 2024
$111K
1,347 services
Medicare patients, 2024
383
Average age 75
Drug cost, 2024
$1.4M
1,787 prescriptions
Company payments, 2025
$282
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Cynthia Recinto was code 99233 (hospital e&m - subsequent), 492 times for 166 patients. In total Cynthia Recinto billed 1,347 services in 8 codes, and Medicare paid $111K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 492 | 166 | $91.77 | $45K |
| 99232 Hospital E&M - Subsequent | Facility | 345 | 143 | $62.77 | $22K |
| 99239 Hospital Discharge Management | Facility | 252 | 239 | $90.76 | $23K |
| 99231 Hospital E&M - Subsequent | Facility | 77 | 37 | $38.85 | $2,992 |
| 99223 Hospital E&M - Initial | Facility | 64 | 62 | $135.54 | $8,674 |
| 99222 Hospital E&M - Initial | Facility | 60 | 58 | $104.11 | $6,247 |
| 99497 Care Management/Coordination | Facility | 49 | 49 | $59.02 | $2,892 |
By year: 2022 $86K for 1,021 services; 2023 $92K for 1,000 services; 2024 $111K for 1,347 services.
Medicare prescription drug claims, 2024
In 2024, the drug Cynthia Recinto prescribed most often to Medicare patients was Atorvastatin Calcium, with 127 prescriptions and refills. In total Cynthia Recinto wrote 1,787 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 127 | 144 | 34 | $681 |
| Pantoprazole Sodium Generic | 80 | 104 | 27 | $606 |
| Metformin Hcl Generic | 68 | 77 | 20 | $390 |
| Amlodipine Besylate Generic | 53 | 54 | 16 | $84.67 |
| Creon Lipase/Protease/Amylase | 52 | 155 | 21 | $453K |
| Levothyroxine Sodium Generic | 47 | 51 | 17 | $182 |
| Famotidine Generic | 47 | 53 | 13 | $250 |
| Metoprolol Tartrate Generic | 46 | 48 | 12 | $83.28 |
| Losartan Potassium Generic | 42 | 58 | 17 | $263 |
| Furosemide Generic | 41 | 51 | 16 | $77.92 |
| Eliquis Apixaban | 37 | 45 | 15 | $24K |
| Invega Trinza Paliperidone Palmitate | 32 | 96 | 14 | $326K |
| Escitalopram Oxalate Generic | 32 | 34 | Under 11 | $216 |
| Tamsulosin Hcl Generic | 30 | 32 | Under 11 | $137 |
| Xarelto Rivaroxaban | 30 | 54 | Under 11 | $29K |
Brand drugs: - claims; generic drugs: 1,404 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Cynthia Recinto $282 ($282 in general payments such as food, travel and fees) from 3 companies. The largest payer was ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) with $251.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.